Journal of Pharmacological Sciences (Jan 2014)

Gabapentin Prevents Oxaliplatin-Induced Mechanical Hyperalgesia in Mice

  • Masahiro Ohsawa,
  • Saki Otake,
  • Tomoyasu Murakami,
  • Shohei Yamamoto,
  • Toshiaki Makino,
  • Hideki Ono

DOI
https://doi.org/10.1254/jphs.14058fp
Journal volume & issue
Vol. 125, no. 3
pp. 292 – 299

Abstract

Read online

Abstract.: Oxaliplatin, a platinum-based chemotherapy drug, frequently causes acute and chronic peripheral neuropathies including mechanical hyperalgesia. These adverse effects hinder anticancer therapy with the drug. In this study, we examined several drugs that might prevent oxaliplatin-induced peripheral neuropathy. Single intraperitoneal (i.p.) injection of oxaliplatin (10 mg/kg) induced cold allodynia (acetone test) and mechanical hyperalgesia (von Frey test). Gabapentin, but not simvastatin and atorvastatin, prevented oxaliplatin-induced mechanical hyperalgesia without affecting cold allodynia. Moreover, oxaliplatin caused phosphorylation of cofilin protein in the spinal cord, which has been shown to be involved in the neuropathic hyperalgesia. This increased phosphorylation of cofilin was also attenuated by gabapentin treatment. These results suggest that gabapentin is useful for relieving oxaliplatin-induced mechanical hyperalgesia and that the pathogenic mechanisms of cold allodynia and mechanical hyperalgesia differ. Keywords:: oxaliplatin, mechanical allodynia, gabapentin, neuropathic pain, cofilin